Procedure to stop bleeding in a brain bleed using a small plug
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial looks at a minimally invasive procedure that may stop bleeding in the space between the brain and its outer covering (a subdural hematoma). It’s being offered to people being evaluated in Canada, and the main goals are to see if the approach is safe and practical for routine use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a subdural hematoma.
- You are being evaluated in the emergency room or a neurosurgery outpatient clinic.
- You (or your substitute decision-maker, if needed) can give consent to join the study.
- The medical team cannot enroll you if consent cannot be obtained from you or your substitute decision-maker.
- You do not have a known allergy to the liquid agent used to block the bleeding vessel.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer way to treat subdural hematoma—a bleeding problem inside the brain. After surgery to drain the blood, you'll receive an additional minimally invasive procedure (middle meningeal artery embolization) using a new device called NeoCast to help prevent the bleeding from coming back.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This study looks at a procedure called middle meningeal artery embolization, which blocks blood flow to the lining of the brain to help treat a chronic subdural hematoma (a slow bleed on the brain surface). The goal is to see how well this procedure works for adults.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests a minimally invasive procedure called middle meningeal artery embolization (using tiny particles to block a small artery) to treat chronic subdural hematoma, a condition where blood slowly builds up on the brain's surface. The goal is to help the body reabsorb the blood and prevent the need for repeated surgeries.
This trial tests a minimally invasive procedure to treat chronic subdural hematoma (a slow bleed on the brain). It aims to stop the bleeding and reduce the risk of needing surgery.
Hear when a new Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.